Formosa Laboratories, Inc. (4746.TW)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Chen-Yu Cheng Ph.D.
|
Chairman, President & Manager | 9.62M | -- | -- |
|
Yu Zhen Luo
|
Head of Accounting & Accounting Supervisor | -- | -- | -- |
|
Ms. Shan-Jan Liou B.S.
|
Senior Vice President of Business | -- | -- | -- |
|
Ms. Yu-Chen Lo
|
Senior Vice President of Corporate Support Division | -- | -- | -- |
|
Mr. Hengui Huang
|
Senior Vice President of Quality & Regulatory Compliance Division | -- | -- | -- |
|
Mr. Hank Chen
|
Senior Vice President of Production | -- | -- | -- |
|
Xian-Gui Huang
|
Vice President | -- | -- | -- |
|
Ling-Fang Yang
|
Vice President | -- | -- | -- |
|
Chien-Fei Lin
|
Chief Information Security Officer | -- | -- | -- |
|
Mr. Chai-Sung Chen
|
Senior Vice President of PD | -- | -- | -- |
Formosa Laboratories, Inc.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. It offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulators, respiratory agents, cholesterol and phosphate binders, UV filter, iron deficiency anemia (IDA), CNS agents, MRI enhancing agents, steroids, antibiotics, and other areas; and injectables in the areas of IDA, MRI agents, oncology, and others. The company also provides contract development and manufacturing services, including recrystallization, filtration, dialysis, column purification, distillation, spray drying, and micronization; injectable manufacturing and secondary packaging, labeling, and serialization services; custom fermentation services; and peptide synthesis services. In addition, it offers antibody-drug conjugates services comprising antibody development and manufacture; peptide and polymer drug conjugation; linker-payload design, synthesis, and manufacturing; bio-conjugation and purification; cytotoxic liquid-filled and lyophilized product from pre-formulation studies to manufacture; and regulatory support. Further, the company is involved in chemical trading and investment activities. Formosa Laboratories, Inc. was incorporated in 1985 and is headquartered in Taoyuan City, Taiwan.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
August 24, 2026 at 12:00 AM UTC
Ex-Dividend Date
